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ABSTRACT
The replication of hepatitis C virus (HCV) is uniquely dependent on a host microRNA, miR-122. Previous studies using genotype
1a H77S.3 virus demonstrated that miR-122 acts in part by protecting the RNA genome from 5= decay mediated by the cytoplas-
mic 5= exoribonuclease, Xrn1. However, this finding has been challenged by a recent report suggesting that a predominantly nu-
clear exoribonuclease, Xrn2, mediates the degradation of genotype 2a JFH1 RNA. Here, we dissect the roles of these two 5= exori-
bonucleases in restricting the replication of different HCV strains and mediating the decay of HCV RNA. Small interfering RNA
(siRNA) depletion experiments indicated that Xrn1 restricts replication of all HCV strains tested: JFH1, H77S.3, H77D (a ro-
bustly replicating genotype 1a variant), and HJ3-5 (a genotype 1a/2a chimeric virus). In contrast, the antiviral effects of Xrn2
were limited to JFH1 and H77D viruses. Moreover, such effects were not apparent in cells infected with a JFH1 luciferase re-
porter virus. Whereas Xrn1 depletion significantly slowed decay of JFH1 and HJ3-5 RNAs, Xrn2 depletion marginally enhanced
the JFH1 RNA half-life and had no effect on HJ3-5 RNA decay. The positive effects of Xrn1 depletion on JFH1 replication were
largely redundant and nonadditive with those of exogenous miR-122 supplementation, whereas Xrn2 depletion acted additively
and thus independently of miR-122. We conclude that Xrn1 is the dominant 5= exoribonuclease mediating decay of HCV RNA
and that miR-122 provides protection against it. The restriction of JFH1 and H77D replication by Xrn2 is likely indirect in na-
ture and possibly linked to cytopathic effects of these robustly replicating viruses.
IMPORTANCE
HCV is a common cause of liver disease both within and outside the United States. Its replication is dependent upon a small,
liver-specific noncoding RNA, miR-122. Although this requirement has been exploited for the development of an anti-miR-122
antagomir as a host-targeting antiviral, the molecular mechanisms underpinning the host factor activity of miR-122 remain in-
completely defined. Conflicting reports suggest miR-122 protects the viral RNA against decay mediated by distinct cellular 5=
exoribonucleases, Xrn1 and Xrn2. Here, we compare the roles of these two exoribonucleases in HCV-infected cells and confirm
that Xrn1, not Xrn2, is primarily responsible for decay of RNA in cells infected with multiple virus strains. Our results clarify
previously published research and add to the current understanding of the host factor requirement for miR-122.
Persistent infections with hepatitis C virus (HCV) are a com-mon cause of chronic and life-threatening liver diseases, in-
cluding cirrhosis and hepatocellular carcinoma (1). A positive-
strand RNA virus classified within the genus Hepacivirus in the
family Flaviviridae, HCV typically infects surreptitiously, causing
little overt disease until late in the course of the infection, often
several decades later. The virus is largely, if not exclusively, hepa-
totropic, but viral RNA and proteins are present only at low abun-
dance in hepatocytes, making their detection difficult by conven-
tional methods (2). HCV also replicates very inefficiently in cell
culture in the absence of adaptive mutations, even in cells lacking
strong innate immune responses (3, 4). In part, this reflects an
unusual sensitivity to oxidative membrane damage that down-
regulates replication and maintains HCV gene expression at low
levels (4). A notable exception is JFH1 virus, a genotype 2a isolate
that is resistant to lipid peroxidation and replicates robustly in
Huh-7 human hepatoma cells without cell culture-adaptive mu-
tations (4–6). To a much greater extent than other HCV strains,
infection with JFH1 causes significant cell injury, resulting in G1
cell cycle arrest and apoptosis (7–9). Nonetheless, because of its
robust replication phenotype, many laboratories have come to
rely on JFH1 for cell-based studies of virus-host interactions.
Many host factors are usurped by HCV to support its replica-
tion (10–13). Among these is a liver-specific microRNA (miRNA),
miR-122 (14, 15). miR-122 binds two sites in the viral genome
close to its 5= terminus, recruiting argonaute 2 protein (AGO2) to
the viral RNA (16, 17). In addition to acting directly to stimulate
viral RNA synthesis (18), miR-122 forms a ternary complex with
AGO2 that protects the viral genome from 5= exonucleolytic decay
in infected cells (17, 19). Thus, supplementing the endogenous
abundance of miR-122 in hepatoma cells by transfection of syn-
thetic duplex miR-122 increases the half-life (t1/2) of viral RNA
following pharmacologic arrest of new viral RNA synthesis in in-
fected cells, while the opposite effect, a reduction in the HCV RNA
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t1/2, can be induced by transfection of antisense oligoribonucle-
otides complementary to the miR-122 guide strand (17).
Previous studies in our laboratory demonstrated that the ma-
jor cytosolic 5= exoribonuclease, Xrn1, is responsible for the deg-
radation of HCV RNA in infected cells (19). These studies used a
cell culture-adapted genotype 1a virus, H77S.3 (20), that repli-
cates less efficiently than JFH1. H77S.3 virus does not induce G1
arrest and also causes substantially less apoptosis in Huh-7 cells
than JFH1 (9). RNA interference (RNAi)-mediated depletion of
Xrn1 slowed the decay of H77S.3 RNA in infected cells and also
ablated the effect of miR-122 supplementation on the stability of
the genome (19). In contrast, depletion of components of the 3=
exosome complex, also involved in host mRNA decay, was with-
out effect. Because Xrn1 depletion and miR-122 supplementation
similarly, but nonadditively, enhanced the stability of the HCV
genome, we concluded that miR-122 protects the viral RNA from
5= decay mediated primarily by Xrn1 (19).
This conclusion was recently challenged by Sedano and Sar-
now (21), who suggested that Xrn2, a well-studied nuclear 5= ex-
oribonuclease (22), is responsible for the degradation of HCV
RNA. These investigators adopted an experimental approach sim-
ilar to that we had described previously (17, 19), examining the
decay of viral RNA in Xrn2-depleted cells after arresting viral RNA
synthesis with a potent NS5B polymerase inhibitor. However, they
used the more cytopathic JFH1 strain of HCV for their studies
(21). The identification of Xrn2 was intriguing, as it has not pre-
viously been shown to have a cytoplasmic function, whereas the
HCV life cycle is thought to be exclusively cytoplasmic (22, 23).
However, Sedano and Sarnow (21) did not compare the effects of
Xrn1 versus Xrn2 depletion on JFH1 replication or the rate of
decay of JFH1 RNA, leaving unresolved the relative contributions
of the two 5= exoribonucleases to decay of viral RNA in JFH1-
infected cells.
Here, we compare the effects of Xrn1 and Xrn2 depletion on
replication of JFH1 and other HCV strains, including HJ3-5, a
chimeric virus with the structural proteins of H77S.3 and the non-
structural proteins and noncoding RNA sequences of JFH1 (24,
25). We measure the impact of depleting these host exoribonu-
cleases on the decay of the HCV genome in infected cells following
arrest of viral RNA synthesis. While we confirm that Xrn2 restricts
JFH1 replication, we show Xrn1 to be the dominant 5= exoribo-
nuclease responsible for decay of viral RNA in both JFH1- and
HJ3-5-infected cells. Our data indicate that the antiviral effects of
Xrn2 are limited to more cytopathic HCV strains and, unlike
Xrn1, are not countered by miR-122 supplementation.
MATERIALS AND METHODS
Cells, viruses, plasmids, and reagents. Huh-7.5 and Huh-7 cells were
maintained as described previously (17, 19). HJ3-5 and JFH viruses (the
latter containing a single, cell culture-adaptive Gln1251-Leu mutation in
NS3) have been described previously (5, 25, 26). Plasmids containing
infectious molecular clones of H77D virus and reporter viruses expressing
Gaussia princeps luciferase (GLuc), pH77S.3/GLuc2A, pHJ3-5/GLuc2A,
and pJFH1/GLuc2A, have also been described (4, 20). RNA transcripts
were prepared from these plasmid DNAs as reported previously (19).
Sofosbuvir was a gift from Ann Sluder, Scynexis, Inc.
Transfections. Small interfering RNA (siRNA) pools targeting Xrn1,
Xrn2, and a control siRNA (siCtrl) pool (Dharmacon) were transfected
using siLentfect Lipid Reagent (Bio-Rad). Duplex synthetic miRNAs (50
nM) (4, 15, 27) were also transfected using siLentfect Lipid Reagent where
indicated. For reporter virus experiments, in vitro-transcribed HCV RNA
(1.25 g) (15) was transfected into 5  105 Huh-7.5 cells using the Tran-
sIT mRNA kit (Mirus Bio).
Preparation of cytoplasmic and nuclear lysates. Huh-7.5 cells were
harvested in lysis buffer A (150 mM KCl, 25 mM Tris-HCl [pH 7.5], 5 mM
EDTA, 1% Triton X-100, 2 mM dithiothreitol [DTT], Complete Protease
Inhibitor Mixture [Roche]). The lysates were centrifuged for 5 min at
1,000  g at 4°C. The supernatants were collected as cytoplasmic lysates.
The nuclear pellet was washed with phosphate-buffered saline (PBS) and
lysed in buffer B (500 mM KCl, 25 mM Tris-HCl [pH 7.5], 2 mM EDTA,
1% NP-40, 0.1% SDS, Complete Protease Inhibitor Mixture [Roche]).
The cytoplasmic and nuclear lysates were clarified by centrifugation at
17,000  g for 10 min at 4°C.
RT-qPCR. To quantify HCV RNA, cDNA was generated by reverse
transcription (RT) using oligo(dT) and an HCV-specific primer (5=-GA
AGAGATATCGGCCGCAAA-3=) targeting the NS5B region of the ge-
nome and SuperScript III Reverse Transcriptase (Invitrogen). Quantita-
tive PCR (qPCR) analysis was carried out using iTaq SYBR green
Supermix with the CFX96 system (Bio-Rad). HCV RNA abundance was
determined using PCR primers targeting the 5= untranslated region
(UTR) (5=-CATGGCGTTAGTATGAGTGTCGT-3= and 5=-CCCTATCA
GGCAGTACCACAA-3=, and normalized to the abundance of -actin
mRNA (primers: 5=-GTCACCGGAGTCCATCACG-3= and 5=-GACCCA
GATCATGTTTGAGACC-3=).
Gaussia luciferase assay. Cell culture supernatant fluids were col-
lected at intervals following transfection of reporter virus RNAs or infec-
tion with reporter viruses, and the cells were refed with fresh medium.
Secreted GLuc activity was measured using the Biolux Gaussia Luciferase
assay kit (New England BioLabs) as previously described (19).
Immunoblots. Immunoblotting was carried out using standard
methods with the following antibodies: mouse monoclonal antibody
(MAb) to HCV core protein (Pierce), rabbit polyclonal antibody (PAb) to
Xrn1 (Bethyl Laboratories), rabbit polyclonal antibody to Xrn2 (Protein-
Tech), and goat PAb to lamin A (Santa Cruz). Protein bands were visual-
ized with an Odyssey Infrared Imaging System (Li-Cor Biosciences).
Confocal immunofluorescence microscopy. Cells were fixed with 4%
paraformaldehyde for 30 min and then stained with rabbit PAb specific
for Xrn1 (Bethyl Laboratories) or Xrn2 (ProteinTech) and a secondary
Alexa-488-conjugated goat anti-rabbit antibody (Invitrogen). HCV core
protein was labeled with mouse anti-HCV core MAb (Pierce) and Alexa-
568-conjugated goat anti-mouse antibody (Invitrogen). Nuclei were
counterstained with DAPI (4=,6-diamidino-2-phenylindole). Confocal
microscopy was carried out using a Leica SP2 laser scanning confocal
microscope.
Cell proliferation assay. The WST-1 (Roche) tetrazolium salt cleav-
age assay for cell proliferation was carried out following the manufactur-
er’s suggested procedure. Huh-7.5 cells (1  104) were grown in 96-well
plates and infected with virus at a multiplicity of infection (MOI) of 0.1.
On the day of infection and at 24-h intervals thereafter, 10 l WST-1
reagent was added to the culture medium, and the cells were incubated for
45 min prior to determining absorbance at 450 nm.
Statistical analysis. Statistical significance was assessed using Prism
6.0e for Mac OS X software (GraphPad Software, Inc.).
RESULTS
Intracellular localization of Xrn1 and Xrn2. Xrn1 is known to be
ubiquitously expressed within the cytoplasm of cells, where it
plays a central role in the 5= exonucleolytic mRNA decay pathway,
whereas Xrn2 possesses similar 5= exoribonuclease activity but is
expressed primarily in the nucleus (22, 28). Xrn2 has been impli-
cated in maintaining the quality of cellular transcripts by regulat-
ing the termination of RNA polymerase II-mediated transcrip-
tion. We confirmed the cytoplasmic localization of Xrn1 versus
the predominantly nuclear localization of Xrn2 in immunoblots
of subcellular fractions prepared from uninfected Huh-7.5 cells
(Fig. 1A). However, as described by Sedano and Sarnow (21), a
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significant amount of Xrn2 was also detected in cytosolic frac-
tions. Since this could reflect contamination due to a small degree
of nuclear membrane rupture, largely unavoidable during the
preparation of such fractions, we also ascertained the intracellular
localization of these proteins using confocal immunofluorescence
microscopy (Fig. 1B). These studies confirmed the cytoplasmic
localization of Xrn1, which was primarily present in small punc-
tate structures that most likely represent P bodies. In contrast,
Xrn2 was predominantly nuclear in its localization, with little def-
inite cytoplasmic signal evident. Sedano and Sarnow suggested
that JFH1 virus infection induced a small increase in expression of
Xrn2 (21). However, we observed neither a quantitative change in
its expression nor a qualitative change in its intracellular localiza-
tion in cells infected with either JFH1 or HJ3-5 virus, a chimera in
which sequence encoding the genotype 1a H77 structural proteins
is placed in the genotype 2a JFH1 background (Fig. 1A and C).
Xrn1 and Xrn2 restriction of HCV replication. In initial ex-
periments, we individually knocked down the expression of Xrn1
and Xrn2 in Huh-7.5 cells by repetitive transfection of gene-spe-
cific siRNAs (Fig. 2A and B). We then infected the cells with HJ3-5
or JFH1 virus at comparable multiplicities and quantified the
abundance of intracellular viral RNA 48 to 64 h later by RT-qPCR.
Depletion of either Xrn1 or Xrn2 (Fig. 2B) significantly enhanced
the abundance of JFH1 RNA compared to that present in cells
transfected with a nontargeting control siRNA, siCtrl (Fig. 2C).
Xrn1 depletion had a similar effect in HJ3-5-infected cells, but
Xrn2 depletion had no discernible effect on the abundance of
FIG 1 Xrn1 and Xrn2 expression and intracellular localization in uninfected and HCV-infected Huh-7.5 cells. (A) Immunoblots of Xrn1 and Xrn2 in
whole-cell lysates and isolated nuclear (Nuc) and cytoplasmic (Cyto) fractions from Huh-7.5 cells with and without infection by the indicated viruses.
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and lamin A were included as controls for cytosolic and nuclear proteins. (B) Immunostaining of
Xrn1 (top) and Xrn2 (bottom) in uninfected Huh-7.5 cells. On the right are merged images with nuclei counterstained with DAPI. Xrn1 labeling is
cytoplasmic and associated with puncta representing P bodies (19); Xrn2 labeling is predominantly nuclear. (C) Xrn2 localization (green) in JFH1-
infected Huh-7.5 cells. Dual labeling with antibody to HCV core protein (red) identifies infected cells. Nuclei are counterstained with DAPI. (B and C)
The size markers represent 20 m.
FIG 2 Impact of Xrn1 or Xrn2 depletion on replication of JFH1 and HJ3-5
viruses. (A) Experimental scheme. Huh-7 or Huh-7.5 cells were transfected
with Xrn1- or Xrn2-specific siRNAs (or control siCtrl) twice prior to infection
with either JFH1 or HJ3-5 virus at an MOI of 0.1. The cells were lysed 48 to 64
h later, and viral RNA was quantified by RT-qPCR. (B) Immunoblots of Xrn1
and Xrn2 72 h after the second siRNA transfection. Actin was included as a
loading control. (C) Relative intracellular HCV RNA abundances 48 to 64 h
after infection, normalized to -actin mRNA, with the mean abundance in
siCtrl-transfected cell set at 100. The results shown represent the means and
SEM from 4 (JFH1) or 2 (HJ3-5) independent experiments, each including 2 to
4 technical replicates. *, P  0.05 compared to siCtrl-transfected cells by a
Mann-Whitney test.
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replicating HJ3-5 RNA. The difference evident between these two
viruses was reproduced in multiple independent experiments.
Similar results were also obtained in Huh-7 cells, from which
Huh-7.5 cells are derived (not shown). Thus, Xrn1 is a host re-
striction factor for both JFH1 and HJ3-5 viruses, but Xrn2 restricts
only JFH1 replication. Since the 5=UTRs of JFH1 and HJ3-5 RNAs
are identical in sequence (as are the 3=UTRs) (24), the restriction
of JFH1 virus by Xrn2 is unlikely to reflect a difference in the
capacity of the 5= exoribonuclease to degrade these genomes. For
the same reason, miR-122 should interact with the 5= binding sites
in these genomes in a similar fashion (27) and protect the two
RNAs equivalently against 5= exonuclease-mediated decay. Thus,
Xrn2 most likely restricts JFH1 replication by a mechanism that is
unrelated to miR-122 or 5= exonucleolytic decay of the viral ge-
nome.
To confirm these results, we assessed the impacts of Xrn1 and
Xrn2 depletion on replication of JFH1- and HJ3-5-based reporter
virus RNAs that express GLuc from sequence inserted between the
p7 and NS2 segments of the genome (JFH/GLuc2A and HJ3-5/
GLuc2A, respectively) (4). We also tested in parallel the impact of
Xrn1 or Xrn2 depletion on replication of a purely genotype 1a
reporter virus RNA (H77S.3/GLuc2A) (20). In these experiments,
replication was initiated by transfection of synthetic viral RNA
following two sequential transfections of siRNA specific for Xrn1
or Xrn2 (Fig. 3A and B). As with the infection experiments shown
in Fig. 2, Xrn1 depletion significantly enhanced the replication of
all three RNAs, as determined by increases in GLuc secreted into
supernatant culture fluids over a period of 72 h (Fig. 3C). In con-
trast, Xrn2 depletion resulted in a significant decrease in the rep-
lication of all three viral RNAs, especially JFH1/GLuc2A. In part,
this may have been due to a small but significant effect of Xrn2
depletion on cell proliferation (Fig. 3D). These data confirm that
Xrn1 is a restriction factor for JFH-1 and HJ3-5, as well as H77S.3
virus (19), and that Xrn2 does not restrict replication of either
HJ3-5 or H77S.3.
The substantial reduction we observed in replication of JFH/
GLuc2A RNA (Fig. 3C) contrasts sharply with the enhanced rep-
lication we observed in JFH1-infected cells after Xrn2 depletion
(Fig. 2). To determine whether this reflects the presence of the
GLuc2A insertion or the use of RNA transfection rather than virus
infection in the experiments shown in Fig. 3C, we infected Xrn1-
and Xrn2-depleted cells with cell-free HJ3-5/GLuc2A or JFH1/
FIG 3 Replication of GLuc reporter virus RNAs in Xrn1- and Xrn2-depleted cells. (A) Experimental scheme. The reporter virus genome organization is shown
at the top, with GLuc sequence inserted between p7 and NS2A. Huh-7.5 cells were transfected with Xrn1- or Xrn2-specific siRNA (or siCtrl) 48 and 24 h prior
to transfection with the indicated GLuc reporter virus RNA. Supernatant culture fluids were subsequently sampled at intervals for GLuc activity. (B) Immunoblot
of Xrn1 and Xrn2. Cell lysates were prepared 72 h after the final siRNA transfection. GAPDH was assessed as a loading control. (C) GLuc activities in supernatant
fluids of cells transfected with H77S.3/GLuc2A, HJ3-5/GLuc2A, or JFH/GLuc2A RNA. The data represent means  SEM from triplicate cultures and are
representative of multiple independent experiments. Secreted GLuc activities diverged from siCtrl-treated cells as shown. The 6-h GLuc value represents
translation of input RNA and thus serves as a transfection control. It did not differ significantly between experimental groups (P  0.95 to 0.99). **, P  0.01, and
***, P  0.001 by two-way analysis of variance (ANOVA) with Holm-Sidak correction for multiple comparisons. (D) WST-1 assay showing differences in cell
mass 4 days after siRNA transfection. *, P  0.05 by one-way ANOVA with Dunnett’s multiple-comparison test. (E) Design of experiments involving infection
of Xrn1- and Xrn2-depleted Huh-7.5 cells with HJ3-5/GLuc2A and JFH1/GLuc2A viruses. (F) GLuc activities in supernatant fluids of cells infected with
HJ3-5/GLuc2A or JFH/GLuc2A viruses at an MOI of 0.02. The data shown represent means  SEM from triplicate cell cultures. *, P  0.05; **, P  0.01; ***,
P  0.001 by two-way ANOVA with correction for multiple comparisons.
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GLuc2A virus and then followed replication of the viruses by
monitoring secreted GLuc activity (Fig. 3E). Similar to the results
obtained in the transfection experiments, Xrn1 depletion signifi-
cantly boosted the replication of both viruses (Fig. 3F). In con-
trast, the only apparent effect of Xrn2 depletion was a minor but
statistically significant reduction in GLuc secretion 48 h after in-
fection with JFH1/GLuc2A virus. Thus, the insertion of the
GLuc2A sequence in JFH1 virus eliminates the Xrn2-mediated
restriction of JFH1 replication shown in Fig. 2C.
The insertion of the GLuc2A sequence in JFH/GLuc2A reduces
the robust replication of JFH1, similar to other foreign-gene in-
sertions in the HCV genome (20, 29). Similarly, although they
share identical nonstructural proteins and 5= and 3= noncoding
RNA sequences, the chimeric construction of HJ3-5 virus renders
its replication phenotype less robust than that of JFH1 (4, 24). It
also reduces its associated cytopathic effects, as reflected in the
absence of G1 arrest and less induction of apoptosis in HJ3-5-
infected cells (9). Consistent with these previously reported cyto-
pathic effects, we confirmed that JFH1 infection significantly
slowed the proliferation of JFH1-infected Huh-7.5 cells, whereas
HJ3-5 infection had little effect on cell proliferation (Fig. 4A).
Thus, we considered the possibility that cytopathic effects associ-
ated with robust replication of unmodified JFH1 virus account for
the differences we observed in the impacts of Xrn2 depletion on
JFH1 versus JFH1/GLuc2A and HJ3-5 replication. To test this
hypothesis, we assessed the effects of Xrn1 versus Xrn2 depletion
on replication of H77D virus, a lipid peroxidation-resistant vari-
ant of H77S.3 with a robust replication phenotype similar to that
of JFH1 virus (4). Like JFH1 virus, H77D generates visible cyto-
pathic effects and significantly slows the proliferation of Huh-7.5
cells (Fig. 4A). Also similar to JFH1 virus, Xrn2 depletion signifi-
cantly boosted H77D replication, although once again, this effect
was less than that observed with Xrn1 depletion (Fig. 4B). Thus,
the ability of Xrn2 to restrict HCV replication appears to be lim-
ited to cytopathic virus strains with robust replication phenotypes
and is not linked to specific 5=-UTR or replicase protein sequence.
Impacts of Xrn1 and Xrn2 depletion on HCV RNA decay. We
next compared how the depletion of Xrn1 or Xrn2 influences the
rate of decay of viral RNA in infected cells. Previous studies of the
effects of Xrn2 depletion did not include such a comparison (21).
To assess RNA decay, we adopted the approach taken originally by
Shimakami et al. (17) (Fig. 5A). Cells were transfected with spe-
cific siRNAs to deplete Xrn1 or Xrn2 (Fig. 5B) and then infected
with either JFH1 or HJ3-5 virus. Once infection was well estab-
lished (64 h), the cells were treated with a high concentration of a
nucleotide inhibitor of NS5B (sofosbuvir) to arrest viral RNA syn-
thesis, and the rate of decay of intracellular HCV RNA was subse-
quently assessed by RT-qPCR. Relative HCV RNA levels were fit-
ted to a one-phase decay model (R2  0.90 to 0.97) (Fig. 5C), and
differences in the estimated decay constant [k, where k  ln(2)/
t1/2] were assessed using the extra sum-of-squares F test (Fig. 5D).
Xrn1 depletion increased the t1/2 of HJ3-5 virus RNA from 8.4 to
14.1 h (P  0.0001), whereas Xrn2 depletion resulted in no change
in the t1/2 of the viral RNA (Fig. 5D). Xrn1 depletion similarly
slowed the decay of JFH1 RNA (t1/2 increased from 6.0 to 10.7 h;
P  0.0001), whereas Xrn2 depletion resulted in only a marginally
significant increase (t1/2 increased from 6.0 to 7.7 h; P  0.053)
(Fig. 5D). Thus, Xrn1 depletion causes a statistically significant
lowering of the rates of decay of both HJ3-5 and JFH1 virus RNAs
in infected cells. Xrn2 depletion has at most only a modest effect
on JFH1 RNA decay and no effect on HJ3-5 virus RNA.
Xrn2 depletion promotes JFH1 replication independently of
miR-122. Our previous studies showed that miR-122 supplemen-
tation and Xrn1 depletion act similarly and nonadditively to en-
hance the stability and slow decay of HCV RNA in cells infected
with the genotype 1a H77S.3 virus (19). Thus, in Xrn1-depleted
cells, miR-122 supplementation has no effect on viral RNA stabil-
ity, indicating that the stabilizing effect of miR-122 is due to its
ability to block Xrn1-mediated decay. We carried out similar stud-
ies in JFH1- and HJ3-5-infected cells, asking whether Xrn2 deple-
tion similarly alters the response to supplementation with exoge-
nous miR-122 versus a control, brain-specific miRNA, miR-124
(Fig. 6). Under the control conditions (miR-124 supplementa-
tion), JFH1 replication was increased in cells depleted of either
Xrn1 or Xrn2 compared with siCtrl-transfected cells (Fig. 6C).
Interestingly, the combined depletion of both Xrn1 and Xrn2 had
an additive effect, further boosting replication and enhancing
JFH1 RNA abundance (P  0.05 by paired t test). Compared with
miR-124, supplementing cells with duplex miR-122 resulted in an
increase in JFH1 RNA in control siCtrl- and siXrn2-depleted cells,
but not Xrn1-depleted or Xrn1- plus Xrn2-doubly depleted cells
(Fig. 6C and D). This difference was highly significant and repro-
ducible in multiple experiments. Thus, Xrn1 depletion and miR-
122 supplementation stimulate JFH1 replication in a nonadditive,
redundant fashion, consistent with a common underlying mech-
anism and miR-122 protection against Xrn1-mediated RNA de-
cay, as reported previously (19). In contrast, Xrn2 depletion acts
additively, suggesting that Xrn2 restricts JFH1 virus replication by
an independent mechanism. Since Xrn2 depletion has only a mar-
ginal effect on JFH1 RNA stability (Fig. 5C), it is likely to impact
other aspects of the HCV life cycle.
Similar experiments in HJ3-5-infected cells confirmed nonad-
ditive, redundant effects of miR-122 supplementation and Xrn1
depletion on replication of the virus (Fig. 6D and E). Again, Xrn2
depletion did not enhance replication of the virus. As with JFH1
virus, miR-122 supplementation significantly stimulated replica-
tion in Xrn2-depleted cells, but not in Xrn1-depleted cells or in
cells depleted of both Xrn1 and Xrn2 (Fig. 6E).
FIG 4 HCV effects on cell proliferation and Xrn2 restriction of H77D virus.
(A) Proliferation of Huh-7.5 cells following infection with various HCV strains
(MOI  0.1). The cells were not transfected with siRNAs. Proliferation was
assessed by WST-1 assay (see Materials and Methods). The data were fitted to
a linear regression model, with differences in rates of proliferation (slopes) of
mock-infected cells assessed by a two-tailed run test. **, P  0.01. (B) Impact
of Xrn1 or Xrn2 depletion on replication of H77D virus. See the legend to Fig.
2C for details. ***, P  0.001, and **, P  0.01 by one-way ANOVA with
Dunnett’s multiple-comparison test.
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DISCUSSION
miR-122 plays an essential role in the HCV life cycle, directly
stimulating viral RNA synthesis while also stabilizing the positive-
strand HCV RNA genome and slowing its decay (17, 18). Xrn1
and Xrn2 share limited sequence homology restricted to their N-
terminal exoribonuclease domains but have very distinct subcel-
lular localization and functions (28). We have shown previously
that Xrn1 and miR-122 have competing effects on the stability and
decay of the HCV genome consistent with a dominant role for this
cytoplasmic 5= exoribonuclease in degradation of HCV RNA (19).
RNAi-mediated depletion of Xrn1 increased the t1/2 of genotype
1a H77S.3 RNA following antiviral arrest of new viral RNA syn-
thesis, and by eliminating 5= exoribonuclease activity ablated the
stabilizing effects of miR-122 on the viral genome (19). Sedano
and Sarnow (21) carried out similar experiments with the geno-
type 2a JFH1 virus but concluded that Xrn2 (not Xrn1) is largely
responsible for HCV RNA decay. They found that Xrn2 restricts
replication of JFH1 virus in cell culture (21), a finding we have
confirmed here (Fig. 2). However, while they demonstrated that
miR-122 can protect JFH1 RNA from recombinant Xrn2-medi-
ated degradation in a cell-free reaction (21), they did not compare
the effects of Xrn1 versus Xrn2 depletion on the stability of JFH1
RNA in infected cells.
In the experiments we describe here, high-grade Xrn2 deple-
tion only marginally enhanced the stability of JFH1 RNA in in-
fected cells, whereas Xrn1 depletion slowed the decay of the RNA
to a much greater extent (Fig. 5C). These results indicate that
Xrn1, not Xrn2, is the primary exoribonuclease responsible for
degradation of JFH1 RNA and are consistent with our earlier stud-
ies with H77S.3 virus (19). We also demonstrated that miR-122
supplementation and Xrn1 depletion have largely redundant,
nonadditive effects on JFH1 replication, whereas Xrn2 depletion
acts in an additive and thus likely miR-122-independent fashion
(Fig. 6C and D). Importantly, whereas Xrn2 restricts replication of
JFH1, it does not restrict HJ3-5 virus, and its depletion has no
measurable impact on the stability of HJ3-5 RNA (Fig. 2C and
5D). In contrast, Xrn1 restricts replication of all 4 viruses we test-
ed: H77S.3, H77D, HJ3-5, and JFH1 (19) (Fig. 2, 3C, and 4B).
Surprisingly, Sedano and Sarnow (21) reported that the t1/2 of
JFH1 RNA was only 1.2 h after arrest of RNA synthesis in infected
cells. This compares with a t1/2 of 6.0 h in the studies we describe
here (Fig. 5D), indicating a much faster turnover of JFH1 RNA in
the cells studied by Sedano and Sarnow (21). The very short RNA
t1/2 reported by Sedano and Sarnow (21) in the absence of Xrn2
depletion thus contrasts sharply with what we observed. By way of
comparison, we found the t1/2 of HJ3-5 virus RNA to be about 8.4
h (Fig. 5D), while our previous studies with the genotype 1a
H77S.3 virus suggested a t1/2 of about 10 h (19). Multiscale mod-
eling of the response to antiviral drugs in patients with chronic
hepatitis C suggested that the t1/2 of HCV RNA in the liver is
approximately 11 h (30).
Although Xrn2 depletion has very different effects on JFH1 and
HJ3-5 replication, these viruses are very closely related. HJ3-5 is a
chimera in which sequences encoding the structural proteins of
H77c virus have been placed in the background of JFH1 (24, 25).
HJ3-5 and JFH1 thus share identical nontranslated RNA and rep-
licase sequences, despite the absence of any effect of Xrn2 on
HJ3-5 replication. These viruses do differ in their abilities to in-
FIG 5 Impacts of Xrn1 and Xrn2 depletion on decay of HCV RNA following antiviral shutdown of new RNA synthesis. (A) Experimental scheme. Huh-7.5 cells
were transfected twice with siRNAs specific for Xrn1 or Xrn2 (or siCtrl) 48 and again 24 h prior to infection with the indicated viruses (MOI  0.1). The cells were
treated with sofosbuvir (SOF) (5.0 M) 64 h after infection (0 h) to arrest viral RNA synthesis and then harvested at intervals, and RNA was extracted for
quantitation of HCV RNA by RT-qPCR. (B) Immunoblots showing abundances of Xrn1 and Xrn2 in siRNA-transfected cells. (C) HCV RNA decay following
addition of sofosbuvir to cultures. The data represent means  SEM from 5 biological replicates studied in 2 independent experiments. The lines were fitted to
a one-phase decay model (R2  0.90 to 0.97). (D) Half-life of HCV RNA  95% confidence intervals (CI) estimated from the one-phase decay model. ***, P 
0.001; **, P  0.01; n.s., not significant by the extra sum-of-squares F test. Note that JFH1 RNA decays significantly more rapidly than HJ3-5 RNA (t1/2  6.4
versus 8.4 h; P  0.01). The results shown are derived from multiple independent experiments, each with technical replicates. The data from one of these
experiments for the HJ3-5 virus appeared previously (18).
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duce cytopathic effects, however. JFH1 is atypical in its capacity to
replicate robustly in cell culture without adaptive mutations (5, 6).
Unlike most other HCV strains, it exerts a distinct cytopathic ef-
fect in infected cell cultures, inducing apoptosis, as well as G1 cell
cycle arrest (7–9). HJ3-5 replicates less robustly than JFH1 be-
cause of its chimeric construction and does not induce G1 arrest; it
also causes significantly less apoptosis than JFH1 (9). Also, as in-
dicated above and in Fig. 5D, HJ3-5 RNA decays more slowly than
JFH1 RNA (P  0.01). Given these multiple differences, we sus-
pect that the restriction of JFH1 replication by Xrn2 may be re-
lated to its robust replication and cytopathic effects. This would
also explain why Xrn2 fails to restrict replication of JFH1/GLuc2A
virus (Fig. 3), the sequence of which differs from that of JFH1 only
in the GLuc2A insertion between the p7 and NS2 regions of the
genome. This insertion impairs the efficiency of replication, mak-
ing JFH1/GLuc2A less cytopathic than its JFH1 parent. A relation-
ship between cytopathic effect and Xrn2 restriction is also consis-
tent with Xrn2 restriction of H77D, a virus with a replication
phenotype rivaling that of JFH1 (4) and that, like JFH1, slows
proliferation of infected cells (Fig. 4). Thus, the restriction of HCV
replication by Xrn2 is not linked to specific virus sequence, but
rather, to the robustness of replication and induced cytopathic
effects. This suggests that it is likely to be an artifact of the JFH1 or
H77D cell culture system.
Could it be argued instead that Xrn2 restriction of the robustly
replicating JFH1 and H77D viruses reflects the situation in the
liver during natural infection and that this effect is simply missed
with the less efficiently replicating H77S.3, HJ3-5, and JFH1/
GLuc2A viruses? While we cannot absolutely exclude such a pos-
sibility, it seems unlikely for several reasons. First, multiple mo-
dalities, including two-photon fluorescence microscopy (2),
fluorescent in situ RNA hybridization (31), and single-cell laser
capture microdissection coupled with qRT-PCR (32), all indicate
that HCV replicates very inefficiently with limited expression of
viral proteins and RNA within individual hepatocytes in the in-
fected human liver. Infected hepatocytes are estimated to contain
no more than 100 copies of the HCV genome (33), far fewer than
JFH1 (or even H77S.3) virus-infected Huh-7.5 cells. Thus, viruses
that replicate less robustly in cell culture, such as H77S.3, are likely
to more closely mimic virus-host cell interactions in vivo. Second,
FIG 6 Impact of miR-122 supplementation on replication of JFH1 and HJ3-5 viruses in Xrn1- and Xrn2-depleted cells. (A) Experimental scheme. Huh-7.5 cells
were transfected with siRNAs specific for Xrn1 or Xrn2, both Xrn1 and Xrn2, or siCtrl 72 and 48 h prior to infection with virus (MOI  0.1). The cells were
supplemented with exogenous duplex miR-122 or miR-124 24 h prior to and again 24 h following infection. Cells were harvested, and HCV RNA was quantified
48 h after infection. (B) Immunoblots showing Xrn1 and Xrn2 protein expression. (C) Relative JFH1 RNA abundances in cells transfected with miR-124 versus
miR-122, with that in siCtrl/miR-124 transfected cells set arbitrarily to 100. #, P  0.05, and ##, P  0.01 by two-tailed paired t test (n  4). The dashed lines
indicate comparisons between miR-124-transfected siCtrl cells and Xrn1-, Xrn-2-, and Xrn1- plus Xrn2-depleted cells; *, P  0.05. (D) Fold increases in JFH1
RNA mediated by miR-122 versus miR-124 supplementation. Deviations above a hypothetical value of 1.0 (no increase) were assessed by a one-sample t test. **,
P  0.01 (n  8 for single depletions and 4 for Xrn1 plus Xrn2 depletion). (E) Relative HCV RNA abundances in cells infected with HJ3-5 virus under the
conditions shown in panel A. The details are as in the legend to panel C. (F) Fold increase in HJ3-5 RNA mediated by miR-122 versus miR-124 supplementation.
Deviations above a hypothetical value of 1.0 (no increase) were assessed by a one-sample t test; *, P  0.05 (n  3). All data shown are representative of multiple
independent experiments.
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JFH1 virus represents a clear outlier among HCV strains, demon-
strating a strong resistance to lipid peroxidation that is not evident
in wild-type genotype 1 HCV or in cell culture-adapted viruses of
multiple genotypes (4). H77D virus shares that resistance (4). A
third point to consider, in addition to the marked cytopathic ef-
fects induced by JFH1 (9), is that JFH1 virus produced in cell
culture does not appear capable of establishing persistent infec-
tion, a hallmark of hepatitis C virus, in chimpanzees, whereas cell
culture-produced H77S.3 virus does (34).
Because Xrn2 depletion and miR-122 supplementation have
additive effects on JFH1 replication (Fig. 6), it is likely that Xrn2
acts via an indirect mechanism to restrict JFH1 replication rather
than by direct 5= exonucleolytic decay of the genome. This would
explain why Xrn2 depletion marginally affects the stability of JFH1
RNA (Fig. 5C and D), despite promoting JFH1 replication to al-
most the same extent as Xrn1 depletion (Fig. 2C). Although we did
not observe measurable leakage of nuclear Xrn2 into the cyto-
plasm in JFH1-infected cells (Fig. 1), it is possible that this occurs
in association with the cytopathic effects of JFH1. Xrn2 has mul-
tiple functions tied to RNA metabolism (22, 28), and aberrant
localization of the protein could have negative consequences for
the cell, resulting in reduced permissiveness for HCV replication.
Importantly, Xrn2 has no influence on the replication of HCV
strains that have less robust cell culture phenotypes than JFH1 or
H77D and little or no cytopathic effect and that are likely to mirror
more closely the biology of HCV in the liver.
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